0001237899-12-000052.txt : 20120502 0001237899-12-000052.hdr.sgml : 20120502 20120502115751 ACCESSION NUMBER: 0001237899-12-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120501 FILED AS OF DATE: 20120502 DATE AS OF CHANGE: 20120502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YANCOPOULOS GEORGE CENTRAL INDEX KEY: 0001226690 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 12803560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0305 4 2012-05-01 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226690 YANCOPOULOS GEORGE 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 EVP CSO President Regeneron Re Common Stock 2012-05-01 4 S 0 100.0 133.95 D 866106.0 D Common Stock 2012-05-01 4 S 0 20120.0 134.54 D 845986.0 D Common Stock 2012-05-01 4 S 0 12945.0 135.29 D 833041.0 D Common Stock 5534.0 I By 401(k) Plan Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 20,120 shares of Company stock on May 1, 2012 at prices ranging from $134.01 to $134.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2012 at each separate price. Represents volume-weighted average price of sales of 12,945 shares of Company stock on May 1, 2012 at prices ranging from $135.01 to $135.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2012 at each separate price. /s/**George D. Yancopoulos 2012-05-02